Literature DB >> 18495553

Modulation of RBC volume distributions by oxidants (phenazine methosulfate and tert-butyl hydroperoxide): role of Gardos channel activation.

Irina L Lisovskaya1, Irina M Shcherbachenko, Rimma I Volkova, Vladimir P Tikhonov.   

Abstract

A study was made comparing the effects of two oxidants--phenazine methosulfate (50-1500 microM)+10 mM ascorbate and t-butyl hydroperoxide (1-3 mM)--on the volume-related parameters of normal human red blood cells. Incubation with either oxidative system for 20-30 min resulted in red blood cell density and osmotic resistance distribution shifts. Treatment with the phenazine methosulfate+ascorbate system in the presence of Ca(2+) led to cell shrinking, with the maximum effect being more than 20%. In contrast, under the same conditions, t-BHP caused cell swelling by up to 15%. Modification of the suspending medium (Ca(2+) removing, clotrimazole addition, or enrichment with K(+)) modulated the redistribution effects, suggesting that they were mediated to some extent by Gardos channel activation. These findings are important for understanding how oxidants modulate RBC cation channels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495553     DOI: 10.1016/j.bioelechem.2008.04.008

Source DB:  PubMed          Journal:  Bioelectrochemistry        ISSN: 1567-5394            Impact factor:   5.373


  3 in total

1.  Effect of the polydispersity of RBCs on the recovery rate of RBCs during the removal of CPAs.

Authors:  Heyuan Qiao; Weiping Ding; Yuncong Ma; Sijie Sun; Dayong Gao
Journal:  Comput Math Methods Med       Date:  2014-12-15       Impact factor: 2.238

Review 2.  Heterogeneity of Red Blood Cells: Causes and Consequences.

Authors:  Anna Bogdanova; Lars Kaestner; Greta Simionato; Amittha Wickrema; Asya Makhro
Journal:  Front Physiol       Date:  2020-05-07       Impact factor: 4.566

Review 3.  Rheological Abnormalities in Human Erythrocytes Subjected to Oxidative Inflammation.

Authors:  Toru Maruyama; Michinari Hieda; Shiro Mawatari; Takehiko Fujino
Journal:  Front Physiol       Date:  2022-02-23       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.